Parallel Trade of pharmaceutical products has become a common phenomenon in many parts of the world, with significant impact on the healthcare systems of the countries involved. An overview of the status quo of parallel trade of pharmaceuticals was performed to investigate its economic, political and legal background as well as to assess its consequences on research, public health, and health care financing.

More: continued here

This entry was posted on Thursday, May 22nd, 2008 at 10:05 am and is filed under Pharma Industry. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.